Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
Completed · Phase 3
Conditions studied: Ventricular Tachycardia
In brief
This study aims to assess whether a combined technique of substrate ablation and ablation of the clinically presenting VT at the site of early activation is superior to ablation of the clinically presenting VT alone, in enhancing long-term success of VT ablation.
Key facts
- Study ID
- NCT01045668
- Run by
- Texas Cardiac Arrhythmia Research Foundation
- People needed
- 120
- Starts
- 2010-01-01
- Expected to finish
- 2014-07-01
- Last updated by the study team
- 2014-08-25
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Previous Myocardial infarction
- Symptomatic, drug-refractory and haemodynamically stable VT following CAD
- Undergoing a VT ablation
- Implanted ICD
You may not qualify if…
- Documented valvular heart disease
- Acute myocardial infarction within the preceding 1 month
- Unstable angina
- Prolonged QT interval
- Patients with hemorrhagic or thrombophilic disorders
- Documented intra-atrial thrombus, tumor or other conditions which prevent easy catheter introduction
Where it is running
- St.David's Medical Center — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.